Sonya Ruedlinger
Psychiatric/Mental Health · Indianapolis, INNPI 1245586718
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $117,060 of the $134,468 with a category attached, or 87.1%. Johnson & Johnson accounts for 97.5% of it on its own, with 18 other manufacturers making up the rest. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 366 payments — averaging $367.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$131K
- AbbVie$750
- Otsuka America Pharmaceutical, Inc.$457
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$441
- Axsome Therapeutics, Inc.$329
- Lundbeck LLC$220
- plus $1K from 13 others
What the payments were for
- Consulting fees$2,6252%
- Speaking & faculty fees$117,06087%
- Travel & lodging$7,1935%
- Food & beverage$7,5436%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 189 | $131,106 |
| AbbVie | 48 | $750 |
| Otsuka America Pharmaceutical, Inc. | 23 | $457 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $441 |
| Axsome Therapeutics, Inc. | 17 | $329 |
| Lundbeck LLC | 11 | $220 |
| Supernus Pharmaceuticals, Inc. | 9 | $176 |
| Tris Pharma Inc | 9 | $165 |
| Noven Therapeutics, LLC | 8 | $152 |
| Neuronetics, Inc. | 2 | $136 |
| Novo Nordisk | 1 | $125 |
| Corium, LLC | 7 | $104 |
| Collegium Pharmaceutical, Inc. | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Biogen | 2 | $55 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Alkermes, Inc. | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$128,607
- Wegovy$125
- VRAYLAR$124
- NEUROSTAR TMS THERAPY SYSTEM$116
How this compares
$134,468 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $17,055 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $750 | $17,05512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Indianapolis
- Devan GravesIndianapolis$12K
- Clyde YanIndianapolis$9K
- Beth DelamboIndianapolis$7K
- Olga Marie JiodioIndianapolis$6K
- Lindsay RussellIndianapolis$5K
- Nina VoigtIndianapolis$5K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Trina GreenwaldMarion$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.